Teva

Teva 'disappointed' by Irish consultants' boycott of its pharmaceuticals, company tells 'Post'

Teva told the Post it remains committed to working constructively with healthcare professionals across Ireland and to supporting patients through the "consistent supply of high-quality medicines."

The logistics center of Teva Pharmaceutical Industries in Shoham
In January, Israel’s Ministry of Defense signed a multi-year contract with Semiconductor Devices valued at approximately $115 million (NIS 380 million).

The curse of being Israel's most valuable company

The logistics center of Teva Pharmaceutical Industries in Shoham

Mega deal: Teva acquires Emalex for approximately $900 million

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience


AION, aMoon up for top scientific innovation award

AION Labs brings together some of the biggest names in pharma, including AstraZeneca, Merck and Pfizer, and aMoon is Israel’s largest health-tech fund.

AION Labs CEO Mati Gil.

Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits

The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.

 Teva building in Kfar Saba

Grapevine: Screaming sumo

Movers and shakers in Israeli society.

 Teva building in Kfar Saba

Teva, Allergan reach $161.5 million opioid settlement with West Virginia

The agreement is the largest state-negotiated settlement in West Virginia history and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

State sues Teva over Copaxone drug royalties

Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.

Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020

Ukrainian refugees offered free medical services in Israel

Many of them are not Jewish and are therefore ineligible for access to universal healthcare in Israel.

 Ukraine refugees wait at stations close to the border

Rhode Island takes Teva to trial in multibillion-dollar opioid case

The multibillion-dollar trial will determine whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.

 Teva building in Kfar Saba

Teva, Texas strike opioid settlement worth $225 million

Teva Pharmaceutical Industries Ltd was facing claims that they fueled an opioid epidemic in Texas by improperly marketing addictive pain medications.

 Teva building in Kfar Saba

Drugmaker Teva fueled opioid addiction in New York, jury finds

New York and Nassau and Suffolk counties had accused the Israel-based drugmaker of engaging in misleading marketing practices that fueled opioid addiction in the state.

 Teva building in Kfar Saba

California judge rules for Israeli Teva in major opioid lawsuit

The lawsuit was originally filed in April, when several California counties accused drugmakers of fueling America's opioid crisis.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.